Company Filing History:
Years Active: 2009
Title: Innovations of Da Gong Wang in Prostate Cancer Diagnosis
Introduction
Da Gong Wang is an accomplished inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of cancer diagnostics, particularly in prostate cancer. With a total of 2 patents, his work focuses on innovative methods for diagnosing and monitoring prostate cancer.
Latest Patents
One of his latest patents involves the use of Pin1 as a marker for prostate cancer. This invention provides methods for diagnosing prostate cancer, measuring its aggressiveness, and identifying cases likely to metastasize. The diagnostic and prognostic assays include antibody-based detection of Pin1 and amplification of Pin1 RNA. These methods can be used alongside traditional prostate cancer diagnostic techniques such as the PSA test, digital rectal exam, and Gleason grading system.
Another significant patent discloses methods for using Pin1 as a marker of abnormal cell growth. This invention includes evaluating the efficacy of treatments for abnormal cell growth, such as cancer, by monitoring Pin1 levels. The levels of Pin1 can be assessed through protein or nucleic acid measurements.
Career Highlights
Da Gong Wang is currently associated with Pintex Pharmaceuticals, Inc., where he continues to advance his research in cancer diagnostics. His innovative approaches have the potential to improve patient outcomes through more accurate and timely diagnoses.
Collaborations
He collaborates with Lere Bao, who is also a key contributor to their research efforts. Together, they work on developing groundbreaking solutions in the field of cancer diagnostics.
Conclusion
Da Gong Wang's contributions to prostate cancer diagnosis through his innovative patents highlight the importance of research in improving healthcare outcomes. His work exemplifies the potential of scientific advancements in the fight against cancer.